ANDASUBCUTANEOUSSOLUTION
Approved
Nov 2021
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
ISOSULFAN BLUE (isosulfan blue) by Medtronic is 12. First approved in 2021.
Drug data last refreshed 18h ago
Mechanism of Action
12.2 Pharmacodynamics Following subcutaneous administration, isosulfan blue 1% binds to serum proteins and is picked up by the lymphatic vessels. Thus, the lymphatic vessels are delineated by the blue dye. 12.3 Pharmacokinetics Up to 10% of the subcutaneously administered dose of isosulfan blue 1%…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Medtronic
NJ - Phillipsburg
Worked on ISOSULFAN BLUE at Medtronic? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.